These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35887801)

  • 21. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum).
    Jhoo JW; Freeman JP; Heinze TM; Moody JD; Schnackenberg LK; Beger RD; Dragull K; Tang CS; Ang CY
    J Agric Food Chem; 2006 Apr; 54(8):3157-62. PubMed ID: 16608246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous quantitation of kavalactones in kava dry extracts: comparison of multi-standards and single standard validation approaches.
    Ferreira JV; Pierotte IC; Pianetti GA; César IC
    Phytochem Anal; 2021 Sep; 32(5):740-748. PubMed ID: 33615586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kava kava: examining new reports of toxicity.
    Clouatre DL
    Toxicol Lett; 2004 Apr; 150(1):85-96. PubMed ID: 15068826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological Activity, Hepatotoxicity, and Structure-Activity Relationship of Kavalactones and Flavokavins, the Two Main Bioactive Components in Kava (
    Wang Y; Su C; Zhang B; Niu Y; Ren R; Zhao X; Yang L; Zhang W; Ma X
    Evid Based Complement Alternat Med; 2021; 2021():6851798. PubMed ID: 34471418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary Pacific and Western perspectives on `awa (Piper methysticum) toxicology.
    Showman AF; Baker JD; Linares C; Naeole CK; Borris R; Johnston E; Konanui J; Turner H
    Fitoterapia; 2015 Jan; 100():56-67. PubMed ID: 25464054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kava as a Clinical Nutrient: Promises and Challenges.
    Bian T; Corral P; Wang Y; Botello J; Kingston R; Daniels T; Salloum RG; Johnston E; Huo Z; Lu J; Liu AC; Xing C
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33027883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
    Weiss J; Sauer A; Frank A; Unger M
    Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating volatiles as the secondary metabolome of Piper methysticum from root powder and water extracts using comprehensive two-dimensional gas chromatography.
    Cheung C; Baker JD; Byrne JM; Perrault KA
    J Ethnopharmacol; 2022 Aug; 294():115346. PubMed ID: 35533912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The integrated use of in silico methods for the hepatotoxicity potential of Piper methysticum.
    Tugcu G; Kırmızıbekmez H; Aydın A
    Food Chem Toxicol; 2020 Nov; 145():111663. PubMed ID: 32827561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kava: herbal panacea or liver poison?
    Moulds RF; Malani J
    Med J Aust; 2003 May; 178(9):451-3. PubMed ID: 12720513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Composition and biological activity of traditional and commercial kava extracts.
    Côté CS; Kor C; Cohen J; Auclair K
    Biochem Biophys Res Commun; 2004 Sep; 322(1):147-52. PubMed ID: 15313185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
    Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
    Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of calcium signalling pathways by components of Piper methysticum ('Awa).
    Shimoda LM; Showman A; Baker JD; Lange I; Koomoa DL; Stokes AJ; Borris RP; Turner H
    Phytother Res; 2015 Apr; 29(4):582-90. PubMed ID: 25640812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoamine Oxidase Inhibition by Kavalactones from Kava (Piper Methysticum).
    Prinsloo D; van Dyk S; Petzer A; Petzer JP
    Planta Med; 2019 Oct; 85(14-15):1136-1142. PubMed ID: 31539917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kava dermopathy.
    Norton SA; Ruze P
    J Am Acad Dermatol; 1994 Jul; 31(1):89-97. PubMed ID: 8021378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid detection and validated quantification of psychoactive compounds in complex plant matrices by direct analysis in real time-high resolution mass spectrometry - Application to "Kava" psychoactive pepper products.
    Chambers MI; Osborne AM; Musah RA
    Rapid Commun Mass Spectrom; 2019 Dec; 33(24):1915-1925. PubMed ID: 31323704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro.
    Einbond LS; Negrin A; Kulakowski DM; Wu HA; Antonetti V; Jalees F; Law W; Roller M; Redenti S; Kennelly EJ; Balick MJ
    Phytomedicine; 2017 Jan; 24():1-13. PubMed ID: 28160848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of kavalactones from Piper methysticum (kava-kava).
    Bilia AR; Scalise L; Bergonzi MC; Vincieri FF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 812(1-2):203-14. PubMed ID: 15556499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constituents in kava extracts potentially involved in hepatotoxicity: a review.
    Olsen LR; Grillo MP; Skonberg C
    Chem Res Toxicol; 2011 Jul; 24(7):992-1002. PubMed ID: 21506562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kava consumption and its health effects.
    Gounder R
    Pac Health Dialog; 2006 Sep; 13(2):131-5. PubMed ID: 18181402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.